Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMPM.L Regulatory News (MPM)

  • There is currently no data for MPM

Total Voting Rights

20 Dec 2006 17:43

Minster Pharmaceuticals PLC20 December 2006 Minster Pharmaceuticals plc20 December 2006 Minster Pharmaceuticals plcTotal Voting Rights and Share Capital In conformity with the Transparency Directive's transitional provision 6, Minster Pharmaceuticals plc is required to notify the market of the following: Minster Pharmaceuticals plc's issued share capital consists of 1,611,286,348 ordinary shares with a nominal value of 0.1 pence each, with voting rights. Minster Pharmaceuticals plc does not hold any ordinary shares in Treasury. Therefore, the total number of voting rights in Minster Pharmaceuticals plc is 1,611,286,348. The above figure of 1,611,286,348 shares may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, Minster Pharmaceuticals plc under the Financial Service Authority's Disclosure and Transparency Rules. Name of contact and telephone number for enquiries: Jeremy P GormanMinster Pharmaceuticals plcCompany Secretary020 7935 0027 Minster Pharmaceuticals plcAudley End Business CentreThe Old Forge, London RoadWendens Ambo, Saffron WaldenCB11 4JLwww.minsterpharma.comRegistered in England and Wales No. 481650 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
6th Jun 20147:00 amRNSAGM Statement
23rd May 20147:00 amRNSContract wins
22nd May 20145:00 pmRNSCompletion of audit
21st May 20145:06 pmRNSAnnual General Meeting
13th May 20147:00 amRNSResults for year ended 31 December 2013
29th Apr 201411:30 amRNSNotice of results & new product launch
31st Mar 20147:00 amRNSTOTAL VOTING RIGHTS
21st Mar 20147:00 amRNSAgreement with Affiliate Window
12th Mar 20143:39 pmRNSDirector/PDMR Shareholding
11th Mar 20144:35 pmRNSBlock Admission Application
7th Mar 20147:00 amRNSNew Customer and Sector Wins
20th Jan 20147:00 amRNSPRE-CLOSE TRADING UPDATE
17th Jan 201410:17 amRNSHoldings in Company
18th Dec 20137:00 amRNSFirst Day of Dealings
5th Mar 20107:00 amRNSOffer Update
5th Mar 20107:00 amRNSCompulsory Acquisition of Minster Shares
17th Feb 20107:14 amRNSBoard Changes, Issue of Deferred Consideration
17th Feb 20107:00 amRNSOffer Update
1st Feb 201012:50 pmRNSDirectorate Change
25th Jan 20105:51 pmRNSEPT Disclosure
20th Jan 201011:59 amRNSRule 8.3- Minster Pharmaceuticals PLC
14th Jan 20104:00 pmRNSPosting of Offer Document
14th Jan 20104:00 pmRNSPosting of Offer Document
13th Jan 20102:27 pmRNSRule 8.3- Minster Pharma PLC
4th Jan 20103:11 pmRNSAcquisition of Minster Pharmaceuticals
4th Jan 20103:11 pmRNSCash Offer
20th Nov 20097:00 amRNSInterim Results
21st Sep 20097:00 amRNSDirectorate Change
15th Sep 20093:31 pmRNSChange of Registered Office
14th Sep 20097:00 amRNSTonabersat at IHS Congress
23rd Jul 20097:00 amRNSSabcomeline Patent Filing
17th Jul 200910:39 amRNSDirector/PDMR Shareholding
6th Jul 20097:00 amRNSPublication of Aura Results
30th Jun 200911:30 amRNSResult of AGM
30th Jun 20097:01 amRNSAGM Statement
30th Jun 20097:00 amRNSRajinder Kumar Appointment
2nd Jun 20095:04 pmRNSAnnual Financial Report
29th May 200910:51 amRNSGrant of Share Option to Director
29th May 200910:47 amRNSDirector/PDMR Shareholding
28th May 20097:00 amRNSPreliminary Results
20th Apr 20097:00 amRNSKarl Keegan appointed CFO
17th Apr 20097:16 amRNSDirectorate Change
11th Feb 20093:39 pmRNSHolding(s) in Company
2nd Feb 20097:00 amRNSTempus Study Results
18th Dec 200811:52 amRNSHolding(s) in Company
4th Dec 20087:00 amRNSUS Licensing Consultant
14th Nov 20087:00 amRNSInterim Results
11th Nov 20087:00 amRNSNotice of Interim Results
22nd Oct 20087:00 amRNSPositive Phase II Results
30th Jun 20087:00 amRNSSymposium at AHS Meeting

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.